e-Drug3D 949 |
cas 144598-75-4 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 3 HOUR Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET 5-HYDROXYTRYPTAMINE 2A RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A |
Download SDF file | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one Formula: Calculated chemical properties: MW 426.49 NB_atoms 31 XLogP 3.08 PSA 78.557 NB_HD 1 NB_HA 7 fsp3 0.52 Lipinski(0=no;1=yes) 1 |
FDA NDA 021999 (label) INN (PALIPERIDONE) INVEGA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2006 NDA 022043 (label) INN (PALIPERIDONE) INVEGA (JANSSEN LP) APPROVAL= AP YEAR= 2007 NEWAPPLICATION NDA 202645 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2015 DISCONTINUED NDA 203802 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (RK PHARMA) APPROVAL= AP YEAR= 2015 DISCONTINUED NDA 205618 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (SUN PHARM) APPROVAL= AP YEAR= 2018 NDA 204452 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (INVENTIA) APPROVAL= AP YEAR= 2019 NDA 204707 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2019 NDA 212807 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (CSPC OUYI) APPROVAL= AP YEAR= 2020 NDA 208643 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (LUPIN) APPROVAL= AP YEAR= 2022 DISCONTINUED NDA 216174 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (ASCENT PHARMS INC) APPROVAL= AP YEAR= 2023 NDA 217445 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2024 NDA 218330 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (ALEMBIC) APPROVAL= AP YEAR= 2024 NDA 218514 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (AJANTA PHARMA LTD) APPROVAL= AP YEAR= 2024 NDA 205559 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (DR REDDYS) APPROVAL= AP YEAR= 2025 NDA 218755 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (ESKAYEF) APPROVAL= AP YEAR= 2025 NDA 203279 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (APOTEX) APPROVAL= AP YEAR= 2026 DISCONTINUED NDA 205402 (pdf not found) INN (PALIPERIDONE) PALIPERIDONE (I3 PHARMS) APPROVAL= AP YEAR= 2026 |
Other links: | |
e-Drug3D 713 |
cas 106266-06-2 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL INTRAMUSCULAR SUBCUTANEOUS |
ATC code |
PK parameters F 70 PERCENT Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET 5-HYDROXYTRYPTAMINE 2A RECEPTOR D(2) DOPAMINE RECEPTOR ALPHA 1 ADRENERGIC RECEPTOR ALPHA 2 ADRENERGIC RECEPTOR H1 HISTAMINIC RECEPTOR PDB Ligand code = 8NU (link to the list of PDB complexes) Download experimental 3D coordinates of 8NU with added hydrogens |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A |
Download SDF file | 3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one Formula: Calculated chemical properties: MW 410.49 NB_atoms 30 XLogP 3.59 PSA 58.689 NB_HD 0 NB_HA 6 fsp3 0.52 Lipinski(0=no;1=yes) 1 |
FDA NDA 020272 (label) INN (RISPERIDONE) RISPERDAL (JANSSEN PHARMS) APPROVAL= AP YEAR= 1993 NDA 020588 (label) INN (RISPERIDONE) RISPERDAL (JANSSEN PHARMS) APPROVAL= AP YEAR= 1996 NDA 021346 (label) INN (RISPERIDONE) RISPERDAL CONSTA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2003 NDA 021444 (label) INN (RISPERIDONE) RISPERDAL (JANSSEN PHARMS) APPROVAL= AP YEAR= 2003 DISCONTINUED NDA 077416 (pdf not found) INN (RISPERIDONE) RISPERIDONE (RANBAXY) APPROVAL= TA YEAR= 2006 NDA 076228 (label) INN (RISPERIDONE) RISPERIDONE (HERITAGE PHARMA AVET) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 076288 (pdf not found) INN (RISPERIDONE) RISPERIDONE (NATCO PHARMA USA) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 077769 (pdf not found) INN (RISPERIDONE) RISPERIDONE (HERITAGE PHARMA AVET) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 077953 (pdf not found) INN (RISPERIDONE) RISPERIDONE (APOTEX INC) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 076879 (pdf not found) INN (RISPERIDONE) RISPERIDONE (DR REDDYS LABS LTD) APPROVAL= AP YEAR= 2008 NDA 077860 (pdf not found) INN (RISPERIDONE) RISPERIDONE (WATSON LABS) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 078040 (pdf not found) INN (RISPERIDONE) RISPERIDONE (ZYDUS PHARMS USA INC) APPROVAL= AP YEAR= 2008 NDA 078269 (pdf not found) INN (RISPERIDONE) RISPERIDONE (RISING) APPROVAL= AP YEAR= 2008 NDA 078707 (pdf not found) INN (RISPERIDONE) RISPERIDONE (RENATA) APPROVAL= AP YEAR= 2008 NDA 078871 (pdf not found) INN (RISPERIDONE) RISPERIDONE (NOVITIUM PHARMA) APPROVAL= AP YEAR= 2008 NDA 079088 (pdf not found) INN (RISPERIDONE) RISPERIDONE (TORRENT PHARMS) APPROVAL= AP YEAR= 2008 NDA 076440 (pdf not found) INN (RISPERIDONE) RISPERIDONE (ANI PHARMS) APPROVAL= AP YEAR= 2009 NDA 076904 (pdf not found) INN (RISPERIDONE) RISPERIDONE (HIKMA) APPROVAL= AP YEAR= 2009 DISCONTINUED NDA 077328 (label) INN (RISPERIDONE) RISPERIDONE (SENORES PHARMS) APPROVAL= AP YEAR= 2009 NDA 077494 (pdf not found) INN (RISPERIDONE) RISPERIDONE (PH HEALTH) APPROVAL= AP YEAR= 2009 NDA 077719 (pdf not found) INN (RISPERIDONE) RISPERIDONE (PHARM ASSOC) APPROVAL= AP YEAR= 2009 DISCONTINUED NDA 078071 (pdf not found) INN (RISPERIDONE) RISPERIDONE (AMNEAL) APPROVAL= AP YEAR= 2009 NDA 078116 (pdf not found) INN (RISPERIDONE) RISPERIDONE (SANDOZ) APPROVAL= AP YEAR= 2009 NDA 078187 (pdf not found) INN (RISPERIDONE) RISPERIDONE (SYNTHON PHARMS) APPROVAL= AP YEAR= 2009 DISCONTINUED NDA 078452 (pdf not found) INN (RISPERIDONE) RISPERIDONE (AUROBINDO PHARMA LTD) APPROVAL= AP YEAR= 2009 NDA 078516 (pdf not found) INN (RISPERIDONE) RISPERIDONE (ZYDUS PHARMS USA) APPROVAL= AP YEAR= 2009 NDA 078528 (pdf not found) INN (RISPERIDONE) RISPERIDONE (SANDOZ) APPROVAL= AP YEAR= 2009 NDA 078740 (pdf not found) INN (RISPERIDONE) RISPERIDONE (WEST WARD PHARMS) APPROVAL= AP YEAR= 2009 DISCONTINUED NDA 078744 (pdf not found) INN (RISPERIDONE) RISPERIDONE (WOCKHARDT BIO AG) APPROVAL= AP YEAR= 2009 DISCONTINUED NDA 078828 (pdf not found) INN (RISPERIDONE) RISPERIDONE (JUBILANT CADISTA) APPROVAL= AP YEAR= 2009 NDA 078909 (pdf not found) INN (RISPERIDONE) RISPERIDONE (APOZEAL PHARMS) APPROVAL= AP YEAR= 2009 NDA 076797 (pdf not found) INN (RISPERIDONE) RISPERIDONE (PRECISION DOSE) APPROVAL= AP YEAR= 2010 DISCONTINUED NDA 077542 (pdf not found) INN (RISPERIDONE) RISPERIDONE (SUN PHARM INDS LTD) APPROVAL= AP YEAR= 2010 NDA 077784 (pdf not found) INN (RISPERIDONE) RISPERIDONE (RATIOPHARM) APPROVAL= AP YEAR= 2010 DISCONTINUED NDA 078474 (pdf not found) INN (RISPERIDONE) RISPERIDONE (SUN PHARM INDS LTD) APPROVAL= AP YEAR= 2010 NDA 079158 (pdf not found) INN (RISPERIDONE) RISPERIDONE (LANNETT CO INC) APPROVAL= AP YEAR= 2010 DISCONTINUED NDA 076996 (pdf not found) INN (RISPERIDONE) RISPERIDONE (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2011 DISCONTINUED NDA 077543 (pdf not found) INN (RISPERIDONE) RISPERIDONE (CHARTWELL MOLECULAR) APPROVAL= AP YEAR= 2011 NDA 090347 (pdf not found) INN (RISPERIDONE) RISPERIDONE (SUN PHARMA CANADA) APPROVAL= AP YEAR= 2011 DISCONTINUED NDA 091384 (pdf not found) INN (RISPERIDONE) RISPERIDONE (AMNEAL PHARMS) APPROVAL= AP YEAR= 2011 NDA 091537 (pdf not found) INN (RISPERIDONE) RISPERIDONE (NATCO PHARMA USA) APPROVAL= AP YEAR= 2011 DISCONTINUED NDA 077493 (pdf not found) INN (RISPERIDONE) RISPERIDONE (PRINSTON INC) APPROVAL= AP YEAR= 2011 NDA 090839 (pdf not found) INN (RISPERIDONE) RISPERIDONE (JUBILANT GENERICS) APPROVAL= AP YEAR= 2011 NDA 201003 (pdf not found) INN (RISPERIDONE) RISPERIDONE (AJANTA PHARMA LTD) APPROVAL= AP YEAR= 2011 NDA 076908 (pdf not found) INN (RISPERIDONE) RISPERIDONE (CHARTWELL RX) APPROVAL= AP YEAR= 2012 DISCONTINUED NDA 079059 (pdf not found) INN (RISPERIDONE) RISPERIDONE (TRIS PHARMA INC) APPROVAL= AP YEAR= 2012 NDA 078464 (pdf not found) INN (RISPERIDONE) RISPERIDONE (SUN PHARM INDS LTD) APPROVAL= AP YEAR= 2013 DISCONTINUED NDA 078036 (pdf not found) INN (RISPERIDONE) RISPERIDONE (SUN PHARM INDS INC) APPROVAL= AP YEAR= 2014 DISCONTINUED NDA 202386 (pdf not found) INN (RISPERIDONE) RISPERIDONE (CHARTWELL MOLECULAR) APPROVAL= AP YEAR= 2015 NDA 210655 (label) INN (RISPERIDONE) PERSERIS KIT (INDIVIOR) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 212849 (label) INN (RISPERIDONE) RYKINDO (SHANDONG LUYE) APPROVAL= AP YEAR= 2023 NDA 213586 (label) INN (RISPERIDONE) UZEDY (TEVA) APPROVAL= AP YEAR= 2023 NDA 214068 (pdf not found) INN (RISPERIDONE) RISPERIDONE (TEVA PHARMS USA INC) APPROVAL= AP YEAR= 2023 NDA 214835 (label) INN (RISPERIDONE) RISVAN (LABS FARMS ROVI SA) APPROVAL= AP YEAR= 2024 DISCONTINUED NDA 205104 (pdf not found) INN (RISPERIDONE) RISPERIDONE (IPCA LABS LTD) APPROVAL= AP YEAR= 2024 NDA 211220 (pdf not found) INN (RISPERIDONE) RISPERIDONE (NANOMI) APPROVAL= AP YEAR= 2025 NDA 218586 (pdf not found) INN (RISPERIDONE) RISPERIDONE (AMNEAL) APPROVAL= AP YEAR= 2025 |
Other links: | |
e-Drug3D 1487 |
cas 199739-10-1 |
CLASS NERVOUS SYSTEM |
ROUTE (list) INTRAMUSCULAR |
ATC code |
PK parameters Solubility VERY SLIGHTLY SOLUBLE IN ETHANOL |
Target TARGET 5-HYDROXYTRYPTAMINE 2A RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A |
Download SDF file | Hexadecanoic acid, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester Formula: Calculated chemical properties: MW 664.89 NB_atoms 48 XLogP 9.11 PSA 83.131 NB_HD 0 NB_HA 8 fsp3 0.69 Lipinski(0=no;1=yes) 0 |
FDA NDA 022264 (label) INN (PALIPERIDONE PALMITATE) INVEGA SUSTENNA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2009 NDA 207946 (label) INN (PALIPERIDONE PALMITATE) INVEGA TRINZA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2015 NDA 211149 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2021 OBSOLETE NDA 211995 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (TOLMAR) APPROVAL= TA YEAR= 2023 NDA 210397 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (PHARMASCIENCE INC) APPROVAL= TA YEAR= 2024 NDA 216228 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (MYLAN PHARMS INC) APPROVAL= TA YEAR= 2024 NDA 215682 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (MYLAN PHARMACEUTICALS INC A VIATRIS CO) APPROVAL= TA YEAR= 2024 NDA 216352 (label) INN (PALIPERIDONE PALMITATE) ERZOFRI (LUYE INNOMIND PHARMA) APPROVAL= AP YEAR= 2024 NDA 216674 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (ACCORD HLTHCARE INC) APPROVAL= TA YEAR= 2025 |
Other links: | |
e-Drug3D 1488 |
cas 199739-10-1 |
CLASS NERVOUS SYSTEM |
ROUTE (list) INTRAMUSCULAR |
ATC code |
PK parameters Solubility VERY SLIGHTLY SOLUBLE IN ETHANOL |
Target TARGET 5-HYDROXYTRYPTAMINE 2A RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A |
Download SDF file | Hexadecanoic acid, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester Formula: Calculated chemical properties: MW 664.89 NB_atoms 48 XLogP 9.11 PSA 82.564 NB_HD 0 NB_HA 8 fsp3 0.69 Lipinski(0=no;1=yes) 0 |
FDA NDA 022264 (label) INN (PALIPERIDONE PALMITATE) INVEGA SUSTENNA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2009 NDA 207946 (label) INN (PALIPERIDONE PALMITATE) INVEGA TRINZA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2015 NDA 211149 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2021 OBSOLETE NDA 211995 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (TOLMAR) APPROVAL= TA YEAR= 2023 NDA 210397 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (PHARMASCIENCE INC) APPROVAL= TA YEAR= 2024 NDA 216228 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (MYLAN PHARMS INC) APPROVAL= TA YEAR= 2024 NDA 215682 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (MYLAN PHARMACEUTICALS INC A VIATRIS CO) APPROVAL= TA YEAR= 2024 NDA 216352 (label) INN (PALIPERIDONE PALMITATE) ERZOFRI (LUYE INNOMIND PHARMA) APPROVAL= AP YEAR= 2024 NDA 216674 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (ACCORD HLTHCARE INC) APPROVAL= TA YEAR= 2025 |
Other links: |